Pharmaceuticals | Invitation to Read the Editor’s Choice Articles in Q3 of 2026

We are pleased to share the following articles selected as Editor’s Choice in Pharmaceuticals (ISSN 1424-8247) in Q3 of 2026.

The complete Editor’s Choice list: https://www.mdpi.com/journal/pharmaceuticals/editors_choice.

1. “CYP2D6 Metabolizer Phenotype Is Associated with Early Antidepressant Discontinuation in the UK Biobank”
by Tehila Cohen, Estee Rebibo Demry, Allan H. Young, K. Kleine Schaars, Mario Juruena, Thomas G. Schulze, Jaakko Kaprio, PSY-PGx Consortium, Roos van Westrhenen and Noam Shomron
Pharmaceuticals 2026, 19(7), 1028; doi.org/10.3390/ph19071028

2. “Possible Signals of Ocular Disorders Associated with Gabapentinoids: A Three-Arm Study”
by Mya Murray, Amira Guirguis, Paul Deslandes, John Martin Corkery, Stefania Chiappini, Mariacristina Parravano and Fabrizio Schifano
Pharmaceuticals 2026, 19(8), 1175; doi.org/10.3390/ph19081175

3. “Entinostat Enhances Antigen-Specific CD8 T-Cell Response to Immunotherapies in Lung Cancer Models”
by Esti Porush, Johnathan Arnon, Baruch Pinchover, Esther Stern, Oz M. Shapira, Didier Jean, Galia Blum, Evalyn Yakobovich, Hanna Wald, Amnon Peled et al.
Pharmaceuticals 2026, 19(7), 1034; doi.org/10.3390/ph19071034

4. “Effect of Formulation and Process Variables on the Stability and Quality Attributes of Digoxin Formulations”
by Rizwan Shaikh, Bhanu P. Dongala, Swaroop J. Pansare, Sunil K. Thota, Mohammad T. H. Nutan, Theresa U. Offili, Mansoor A. Khan and Ziyaur Rahman
Pharmaceuticals 2026, 19(8), 1185; doi.org/10.3390/ph19081185

5. “Critical Evaluation of Key Elements in Manufacturing Procedures and Testing Methodologies for Ocular Anti-Infective Thin Film Inserts”
by Alfredo Desiato, Affiong Iyire and Raquel Gil-Cazorla
Pharmaceuticals 2026, 19(8), 1222; doi.org/10.3390/ph19081222

6. “Development and Validation of an LC–MS/MS Method for Simultaneous Quantification of Pazopanib, Cabozantinib, Sorafenib, Axitinib, Tivozanib, Sunitinib, and the Metabolites Sorafenib N-Oxide and Desethyl-Sunitinib in Human Plasma”
by Eva Greibe, Jakob N. Henriksen, Niels Fristrup and Elke Hoffmann-Lücke
Pharmaceuticals 2026, 19(8), 1180; doi.org/10.3390/ph19081180

7. “LC–MS/MS Chemical Profiling and HPLC/PDA Quantification of Hypericum perforatum Extract and Its Anti-Inflammatory Properties”
by Sang-Yun Lee, Yu Ri Jeong, Hak-Dong Lee, Hyoung Su Park, Hye-Jeong See, Ah Young Lee and Sanghyun Lee
Pharmaceuticals 2026, 19(8), 1136; doi.org/10.3390/ph19081136

8. “Clinical Applications and Evidence Landscape of Thymosin Alpha 1 as an Immunomodulatory Adjunct in Cancer Care: A Scoping Review”
by Soo-Dam Kim, Kyu Ri Kim, Dong-Hyeon Kim, Taekyung Yeo, Mi-Jeong Choi, So-Jung Park and Hwa-Seung Yoo
Pharmaceuticals 2026, 19(9), 1492; doi.org/10.3390/ph19091492

9. “Lycopus lucidus Extract Attenuates Testosterone Propionate-Induced Benign Prostatic Hyperplasia in Rats”
by Sueyoung An, Chan Ho Park, Enmei Gao and Jungbin Song
Pharmaceuticals 2026, 19(9), 1478; doi.org/10.3390/ph19091478

10.  “Marjoram Extract Modulates Ion Currents, Intracellular Calcium Signaling, and MTT-Reducing Activity in Bovine Chromaffin Cells and Rat Cortical Neurons”
by Ricardo de Pascual, María Arribas Tejedor, Sara Amor, Laura Jaime, Marisol Villalva, Susana Santoyo, Victoria Jimenez Carretero, Minerva Reyes Almodovar, Javier Hernández Campano, Miriam Granado et al.
Pharmaceuticals 2026, 19(9), 1493; doi.org/10.3390/ph19091493

11. “System Performance Check (SPC): A Readiness Companion to Multi-Attribute Method (MAM) Analysis in Biopharmaceutical Quality Control”
by Jahziel Chase, Melissa Sato, Gordon Slysz, Mahsan Miladi, Mike Knierman, Robert Barkovich and Jared Auclair
Pharmaceuticals 2026, 19(8), 1240; doi.org/10.3390/ph19081240

12. “Beyond Psoriasis Skin Clearance: Effects of Bimekizumab and Tildrakizumab on Systemic Inflammation and Immune-Nutrition Status”
by Elena Campione, Fabio Artosi, Pamela Masci, Chiara Cattani, Giulia Marrone, Sara Lambiase, David Della-Morte, Luca Bianchi and Francesca Pacifici
Pharmaceuticals 2026, 19(10), 1523; doi.org/10.3390/ph19101523

13. “Phage Display as a Promising Platform for Peptide Drug Discovery”
by Babak Bakhshinejad and Andreas Kjaer
Pharmaceuticals 2026, 19(8), 1265; doi.org/10.3390/ph19081265

14. “Dual PROTACs Versus Dual Inhibitors in Oncology: A Medicinal Chemistry and Linker Design Perspective”
by Nicolò Bisi and Abdallah Hamze
Pharmaceuticals 2026, 19(8), 1146; doi.org/10.3390/ph19081146

15. “Integrating Molecular Similarity and AlphaFold-Based Structural Alignment for Target Discovery in Trypanosoma cruzi”
by Albert Ros-Lucas, Nieves Martínez-Peinado, Juan Carlos Gabaldón-Figueira, Maria Morillo-Osorio, Cristina Ballart, Montserrat Gállego, María-Jesús Pinazo, Joaquim Gascón, Ana Requena-Méndez and Julio Alonso-Padilla
Pharmaceuticals 2026, 19(7), 1046; doi.org/10.3390/ph19071046

16. “Effects of Treatment with Citicoline Plus Nicotinamide Oral Solution on Retinal Ganglion Cells and Visual Pathways in Glaucomatous Impairment”
by Vincenzo Parisi, Dario Romano, Amir Ali Aminoleslami, Lucia Ziccardi, Rebecca Prandini, Salvatore Martella and Luca Rossetti
Pharmaceuticals 2026, 19(8), 1179; doi.org/10.3390/ph19081179

17. “MC-NODE: A Mechanism-Decomposed Neural Differential Model for PLGA Microsphere Drug Release Prediction and Attribution”
by Zi’an Tang, Hui Li, Tianfu Li and Feng Xue
Pharmaceuticals 2026, 19(8), 1227; doi.org/10.3390/ph19081227

18. “From DNA-Encoded Chemistry to Tumor-Targeted Small Molecule Therapeutics”
by Samuele Cazzamalli and Dario Neri
Pharmaceuticals 2026, 19(8), 1137; doi.org/10.3390/ph19081137

19. “Selective CXCR4-Targeting Radioconjugates Derived from LY2510924: Evaluation of [¹⁸F]AlF-NOTA-SC, [¹⁷⁷Lu]Lu-BL02, and [¹⁶¹Tb]Tb-BL02 for Theranostic Development”
by Muriel Aline Spahn, Tom Van Loy, Christophe M. Deroose, Sofie Celen, Dominique Schols, Guy Bormans, Janke Kleynhans and Frederik Cleeren
Pharmaceuticals 2026, 19(8), 1160; doi.org/10.3390/ph19081160

20. “Targeting Immune Checkpoint Proteins in Cancer Therapy and the Potential of RNAi-Based Immunotherapy”
by Katherine Kaixin Wang and Ai-Ming Yu
Pharmaceuticals 2026, 19(8), 1212; doi.org/10.3390/ph19081212

21. “Using Deep Learning Models of Gene Regulation to Guide Drug Prioritization”
by Xiaoqin Huang and Ivan Ovcharenko
Pharmaceuticals 2026, 19(7), 1097; doi.org/10.3390/ph19071097

22. “An Integrated Consensus Machine Learning and Structure-Based Workflow for the Discovery of Novel Tankyrase 1 Inhibitors”
by Marina Bilotta, Adriana Gargano, Roberta Rocca, Valentina Maggisano, Stefania Bulotta and Stefano Alcaro
Pharmaceuticals 2026, 19(8), 1310; doi.org/10.3390/ph19081310